Status:
UNKNOWN
Study of the Effects of Pomegranate Tablets on Enlarged Prostates
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Pomegranate Health
Jarrow Pharmaceuticals
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
18+ years
Phase:
PHASE1
Brief Summary
To determine whether pomegranate tablets have a therapeutic effect on Benign Prostatic Hyperplasia.
Detailed Description
Patients with newly diagnosed benign prostatic hyperplasia (BPH) will be recruited from the urology clinic at UCI medical center for this study as indicated in section 4. Once recruited, patients will...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Clinically diagnosed with mild to moderate BPH (AUA symptom score \<20)
Exclusion
- Patient with severe BPH (AUA symptom score \>21)
- Currently using any other forms of medical therapy, prescription finasteride, terazosin, tamsulosin or propecia (for hair loss).
- Prior Transurethral resection of the prostate (TURP).
- Using non-prescription supplements such as Saw Palmetto, B-sitosterol, vitamin E, and quercetin.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00381108
Start Date
September 1 2005
End Date
June 1 2010
Last Update
January 6 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Long Beach
Long Beach, California, United States, 90822
2
University of California, Irvine-Department of Urology
Orange, California, United States, 92868